Bicoll project at BIOTECHNICA, Hannover
Project forum Biotechnology, BIOTECHNICA, Hall 9, Expo Hannover. Dr. Kai Lamottke presented the BMBF project OLNORME “Deorphanising a Nuclear Receptor: Ligandenfindung mit pflanzlichen Naturstoffen”.
Bicoll as Partner of a € 2.7 M European-Funded Euro TransBio Program; Olnorme II Program Focuses on the Development of a New Class of Drug Candidates for the Prevention and Treatment of Cardio Metabolic Diseases with an Inflammatory Component
Munich, Germany – May 11, 2011 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, will be responsible for roughly …